<DOC>
	<DOCNO>NCT00210184</DOCNO>
	<brief_summary>The number patient 70 year old cancer increase France . This population heterogenous : physiological function , presence co-morbidities , autonomy vary lot subject age . Physicians hesitate treat optimal dos afraid risk toxicity spite benefit treatment . Fifty eight percent gastric cancer diagnose patient age 70 France . FOLFIRI ( irinotecan , leucovorin fluorouracil ) chemotherapy appear promising treatment digestive cancer . It increase level response survival without major toxicity . It become necessary evaluate patient , propose adapted treatment condition . The principal objective demonstrate efficacy treatment , safety , survival find geriatric assessment data help well predict chemotherapy toxicity . The researcher plan accrue 43 patient diagnose locally advanced metastatic gastric cancer . They receive FOLFIRI 4 geriatric evaluation : treatment , day 1 cycle 2 , day 1 cycle 4 end chemotherapy . These evaluation include test cognitive function ( MMS ) , nutritional status ( MNA ) , co-morbidity ( CIRS-G ) , mobility ( Get Go ) , activity ( ADL ; IADL ) , quality life ( QLQ-C30 ) , depression ( GDS-15 ) Lachs-Balducci screening .</brief_summary>
	<brief_title>Evaluation Efficacy Safety FOLFIRI Association Treatment Patients 70 Years Age Older With Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>70 year age old Gastric cancer , locally advance metastatic No previous adjuvant treatment ( surgery , radiotherapy , chemotherapy ) last 6 month One measurable lesion ECOG &lt; 3 Biology biochemistry within normal limit Life expectancy &gt; 12 week Other palliative chemotherapy cancer Other cancer last 5 year Previous treatment irinotecan Atropine treatment possible Concomitant cancer therapy except bone radiotherapy Metastases brain meninges symptoms Other severe pathology uncontrolled Problem compliance</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Chemotherapy</keyword>
	<keyword>gastric cancer</keyword>
	<keyword>geriatric evaluation</keyword>
	<keyword>efficacy</keyword>
	<keyword>safety</keyword>
</DOC>